The Endocannabinoid System Plays a Key Role in Placenta Development, Which Cannabis May Disrupt
A review found that the endocannabinoid system is involved in normal placenta development, and THC exposure can disrupt trophoblast cell proliferation, death, and function, potentially explaining cannabis-related fetal growth restriction.
Quick Facts
What This Study Found
This review examined how the endocannabinoid system participates in normal human placenta development and how cannabis use may disrupt this process.
The endocannabinoid system is expressed in human placentas and plays roles in trophoblast cell proliferation, apoptosis (programmed cell death), differentiation, and function. Abnormal expression of this system has been associated with infertility and miscarriages.
THC, which activates the same cannabinoid receptors as endogenous endocannabinoids, can interfere with these tightly regulated processes. The review argued that this provides a biological mechanism for the clinical observation that cannabis use during pregnancy is associated with fetal growth restriction.
Key Numbers
No specific quantitative data presented. The review synthesized findings on cannabinoid receptor expression in placental tissue and the effects of eCBs and THC on trophoblast cell behavior.
How They Did This
Review article examining published literature on endocannabinoid system expression and function in normal and pathological human placentas, and the effects of THC and endocannabinoids on trophoblast biology.
Why This Research Matters
Understanding the biological mechanisms by which cannabis affects pregnancy outcomes is important for both clinical advice and research priorities. This review moves beyond epidemiological associations to provide mechanistic explanations for fetal growth restriction.
The Bigger Picture
The endocannabinoid system turns out to be important in many reproductive processes, from implantation to placental development to fetal growth. This creates multiple points at which cannabis use could interfere with normal pregnancy progression.
What This Study Doesn't Tell Us
Much of the evidence comes from in vitro studies of placental cells rather than whole-organism research. The concentrations of cannabinoids used in cell studies may not reflect actual placental exposure during cannabis use. Individual variability in placental cannabinoid receptor expression is not well characterized.
Questions This Raises
- ?At what gestational stage is the placenta most vulnerable to cannabinoid disruption?
- ?Could CBD-only products affect placental development through the same mechanisms?
Trust & Context
- Key Stat:
- THC disrupts the endocannabinoid signaling that normally guides placental development
- Evidence Grade:
- This is a mechanistic review drawing on cell biology and placental tissue studies, providing moderate evidence for a biological pathway linking cannabis to fetal growth restriction.
- Study Age:
- Published in 2016. Research on cannabis and placental biology has continued to advance.
- Original Title:
- The endocannabinoid system: A novel player in human placentation.
- Published In:
- Reproductive toxicology (Elmsford, N.Y.), 61, 58-67 (2016)
- Authors:
- Costa, M A
- Database ID:
- RTHC-01132
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
How does cannabis affect the placenta?
The placenta uses the endocannabinoid system to regulate its own development. THC from cannabis activates the same receptors, potentially disrupting the carefully balanced signaling that controls placental cell growth, death, and function. This disruption may lead to impaired nutrient transfer to the fetus.
Is any amount of cannabis safe during pregnancy?
This review provides biological evidence for how THC can interfere with placental development, but did not establish a safe threshold. Major medical organizations generally advise against cannabis use during pregnancy based on the available evidence.
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-01132APA
Costa, M A. (2016). The endocannabinoid system: A novel player in human placentation.. Reproductive toxicology (Elmsford, N.Y.), 61, 58-67. https://doi.org/10.1016/j.reprotox.2016.03.002
MLA
Costa, M A. "The endocannabinoid system: A novel player in human placentation.." Reproductive toxicology (Elmsford, 2016. https://doi.org/10.1016/j.reprotox.2016.03.002
RethinkTHC
RethinkTHC Research Database. "The endocannabinoid system: A novel player in human placenta..." RTHC-01132. Retrieved from https://rethinkthc.com/research/costa-2016-the-endocannabinoid-system-a
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.